Assertio Holdings, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Rhea-AI Summary

Assertio Holdings, Inc. (Nasdaq: ASRT) announced the release date for its first quarter 2023 financial results, which is set for May 9, 2023, after market close. Following this release, management will conduct a live webcast earnings conference call at 4:30 p.m. Eastern Time. Investors can access the call via the company's investor relations website. A replay will be available approximately two hours after the call concludes.

Assertio is a specialty pharmaceutical company focused on offering differentiated products to patients. It utilizes a non-personal promotional model and is actively building its commercial portfolio through existing products and potential acquisitions or licensing of approved products.

Positive

• Scheduled release of Q1 2023 financial results on May 9, 2023, may indicate transparency and investor engagement.

Negative

• None.

LAKE FOREST, Ill., April 27, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-929-201-5912.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About Assertio
Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
mkreps@darrowir.com  

FAQ

When will Assertio Holdings release its Q1 2023 financial results?

Assertio Holdings will release its Q1 2023 financial results on May 9, 2023, after the market close.

What time is the Assertio earnings conference call?

The earnings conference call will take place at 4:30 p.m. Eastern Time on May 9, 2023.

How can I access the Assertio earnings call?

You can access the earnings call via the Assertio investor relations website.

Will there be a replay of the Assertio earnings call?

Yes, a replay of the earnings call will be available approximately two hours after the call on Assertio's investor website.

What does Assertio Holdings focus on as a company?

Assertio Holdings focuses on offering differentiated pharmaceutical products and building its commercial portfolio through existing products and acquisitions.